![](/img/cover-not-exists.png)
A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab, and veliparib (ABT-888) in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: A Gynecologic Oncology Group study
Landrum, L.M., Brady, W.E., Armstrong, D.K., Moore, K.N., DiSilvestro, P.A., O'Malley, D.M., Tenney, M.E., Rose, P.G., Fracasso, P.M.Volume:
137
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2015.01.053
Date:
April, 2015
File:
PDF, 104 KB
english, 2015